Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM53 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | FAM188A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | RNFT2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | SCLT1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | NAP1L5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | PRCD | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | MT-CO2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | XRCC2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | OMP | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | MIA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |